Omnicell, Inc.

NASDAQ:OMCL

Medical - Healthcare Information Services

Healthcare
$34.66 -1.49%

-$0.58 today

Market cap
$1.59B
Beta
0.96
P/E (TTM)
84.1
EPS (TTM)
$0.45
52W Low $26.85High $55.00

Volume 0.34M

Average 0.57M

OMCL Weighted Avg Shares (Diluted)

Average shares outstanding including dilutive securities, used to calculate diluted EPS.

Omnicell, Inc.NASDAQ: OMCL

Weighted Avg Shares (Diluted) · Q1 FY2026 · quarter ended Mar 2026

Weighted avg shares (diluted) declines year over year

Q1 FY2026 weighted avg shares (diluted) of 45.94M shares fell 1.4% year over year, behind the -0.8% change in trailing-twelve-month weighted avg shares (diluted). Sequentially, it rose 2.2% from the prior quarter. Over 3 fiscal years it compounded at +0.3% a year.

Context

  • Weighted avg shares (diluted) increased in 2 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from -1.4% toward the trailing-twelve-month pace of -0.8%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
45.94M+2.2% QoQ
Last fiscal yearDec 2025
46.36M+0.2% YoY
LTMMar 2026
45.95M-0.8% YoY
Weighted Avg Shares (Diluted) past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-1.4%——
1 year+0.2%——
3-year CAGR+0.3%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares (Diluted) history

Shares · from the income statement

Latest · FY2025
46.36M USD
Year-over-year change
+0.2%
4-year CAGR
-0.8%

Weighted Avg Shares (Diluted) vs competitors

How OMCL compares with its peers on the latest reported figures

  • OMCL's LTM Mar 2026 weighted avg shares (diluted) of 45.95M shares is the 10th highest of the 11 companies compared; the peer median is 80.58M shares.
  • Its year-over-year change of -0.8% is the 9th highest of 11, against a peer median of +2.5%.
  • Over three fiscal years its annual growth of +0.3% compares with a peer median of +2.1%.
OMCL Competitors Peer median
Weighted Avg Shares (Diluted) for OMCL and competitors
Company Period LTM YoY 3-year CAGR
GDRXGoodRx Holdings, Inc.LTM Mar 2026346.79M -9.7%-4.7%
SSIISS Innovations International, Inc.LTM Mar 2026202.43M +12.0%+268.2%
TDOCTeladoc Health, Inc.LTM Mar 2026176.73M +2.7%+3.0%
TXG10x Genomics, Inc.LTM Sep 2026129.04M +4.4%+3.1%
PGNYProgyny, Inc.LTM Jun 202686.65M -5.9%-3.6%
SDGRSchrödinger, Inc.LTM Sep 202674.52M +1.8%+1.1%
PHRPhreesia, Inc.LTM Apr 202661.07M +5.0%+5.5%
OMDAOmada HealthLTM Mar 202658.08M +4.2%+1.6%
ASTHAstrana Health, Inc.LTM Mar 202649.38M +2.4%+2.7%
OMCLOmnicell, Inc.LTM Mar 202645.95M -0.8%+0.3%
UFPTUFP Technologies, Inc.LTM Jun 20267.79M +0.2%+0.6%
Peer median (excluding OMCL) 80.58M+2.5%+2.1%

Competitors are the stored peer set for OMCL. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue1.13B1.3B1.15B1.11B1.18B
Cost of Revenue577.37M706.96M647.18M641.24M676.8M
Gross Profit554.65M588.99M499.93M471M508.04M
Gross Margin49.0%45.4%43.6%42.3%42.9%
Research & Development75.72M104.97M93.29M90.41M87.74M
Selling, General & Admin389.43M486.34M425.97M380.25M408.64M
Operating Expenses465.15M591.31M519.26M470.67M496.38M
Depreciation & Amortization84.93M99.17M95.56M89.76M86.63M
EBITDA173.33M96.85M79.98M119.87M101.87M
EBITDA Margin15.3%7.5%7.0%10.8%8.6%
Operating Income89.51M(2.32M)(19.33M)337K11.67M
Operating Margin7.9%-0.2%-1.7%0.0%1.0%
Interest Income0014.76M24.9M11.9M
Interest Expense22.39M130K04.53M3.91M
Other Income / Expenses(23.5M)(130K)(779K)25.26M(340K)
Income Before Tax66.01M(2.45M)(20.11M)25.59M11.33M
Pre-Tax Margin5.8%-0.2%-1.8%2.3%1.0%
Income Tax Expense(11.84M)(8.1M)263K13.06M9.27M
Net Income77.85M5.65M(20.37M)12.53M2.05M
Net Margin6.9%0.4%-1.8%1.1%0.2%
EPS (Basic)1.790.13(0.45)0.270.04
EPS (Diluted)1.620.12(0.45)0.270.04
Weighted Avg Shares43.48M44.4M45.21M46.05M45.97M
Weighted Avg Shares (Diluted)47.94M45.89M45.21M46.26M46.36M

Omnicell, Inc.

NASDAQ:OMCL

Intrinsic Alpha fair value

Locked

Current Price

$34.66

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.